发明名称 |
Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor |
摘要 |
This invention features the use of the spirolaxine of formula (I) for the treatment of those pathologies responding to the activation of the PPARgamma receptor, such as the Type 2 insulin-resistant diabetes. This invention also features a pharmaceutical composition in which the spirolaxine of formula (I) acts as active principle in association with the all-trans retinoic acid of formula (II) for the treatment of those pathologies responding to the activation of the PPARgamma receptor, such as the acute malignant haemopathies.
|
申请公布号 |
US2004242675(A1) |
申请公布日期 |
2004.12.02 |
申请号 |
US20040889030 |
申请日期 |
2004.07.13 |
申请人 |
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. |
发明人 |
PISANO CLAUDIO;RICCIONI TERESA |
分类号 |
C07D493/10;A61K31/203;A61K31/365;A61K45/00;A61K45/06;A61P3/10;A61P5/50;A61P7/00;A61P35/00;A61P35/02;A61P43/00;(IPC1-7):A61K31/365 |
主分类号 |
C07D493/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|